Anxiolytic effects of Stachys lavandulifolia Vahl on the elevated plus-maze model of anxiety in mice

Journal of Ethnopharmacology

Volumn 89, Issue 2-3, 2003, Pages 271-276

  Rabbani, M ^a   Sajjadi, S E ^a   Zarei, H R ^a  

^a ISFAHAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Anxiety; Elevated Plus maze; Stachys lavandulifolia Vahl

Indexed keywords

ALCOHOL; DIAZEPAM; ESSENTIAL OIL; KETAMINE; PLANT MEDICINAL PRODUCT; STACHYS LAVANDULIFOLIA EXTRACT; UNCLASSIFIED DRUG;

ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANIMAL MODEL; ANXIETY; ARTICLE; CONTROLLED STUDY; DRUG EFFECT; LOCOMOTION; LOW DRUG DOSE; MALE; MAZE TEST; MEDICINAL PLANT; MOUSE; NONHUMAN; SLEEP TIME; STACHYS LAVANDULIFOLIA; TASK PERFORMANCE; TRANQUILIZING ACTIVITY;

STACHYS LAVANDULIFOLIA;

EID: 0242552339     PISSN: 03788741     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jep.2003.09.008     Document Type: Article

References (28)

1. Amin, G., 1991. Popular Medicinal Plants of Iran. Iranian Research Institue of Medicinal Plants, Tehran, p. 80.
2. Andrews J.S., Stephens D.N. Drug discrimination models in anxiety and depression. Pharmacology and Therapeutics. 47:1990;267-280.
3. Basaran A.A., Calis C., Anklin S., Nishibe S., Sticher O. Lavandulifolioside: a new phenylpropanoid glycoside from Stachys lavandulifolia. Helvetica Chimica Acta. 71:1988;1483.
4. Bastidas Ramirez B.E., Navarro R.N., Quezada Arellano J.D., Ruiz M.B., Villanueva Michel M.T., Garzon P. Anticonvulsant effects of Magnolia grandiflora L. in the rat. Journal of Ethnopharmacology. 61:1998;143-152.
5. "British Pharmacopoeia" 1988, vol. 2. HMSO, London, pp. 137-138.
6. Chalchat J.C., Petrovic S.D., Maksimovic Z.A., Gorunovic M.S. Essential oil of Stachys officinalis (L.) Trevis., Lamiaceae from Montenegto. Journal of Essential Oil Research. 13:2001;286-287.
7. Eisenberg D.M., Davis R.B., Ettner S.L., Appel S., Wilkey S., Van Rompay M., Kessler R.C. Trends in alternative medicine use in the United States, 1990-1997: results of a follow-up national survey. Journal of the American Medical Association. 280:1998;1569-1575.
8. Evans, W.C., 1996. Trease and Evans' Pharmacognosy. W.B. Saunders Company Ltd., London.
9. File S.E. The use of social interaction as a method for detecting anxiolytic activity of chlordiazepoxide-like drugs. Journal of Neuroscience Methods. 2:1980;219-238.
10. File S.E. The contribution of behavioural studies to the neuropharmacology of anxiety. Neuropharmacology. 26:1987;877-886.
11. Handley S.L., Mithani S. Effects of alpha-adrenoceptor agonists and antagonists in a maze-exploration model of 'fear'-motivated behaviour. Naunyn Schmiedebergs Archive of Pharmacology. 327:1984;1-5.
12. Hogg S. A review of the validity and variability of the elevated plus-maze as an animal model of anxiety. Pharmacology, Biochemistry and Behavior. 54:1996;21-30.
13. Kobzar A.Y. Phytochemical study of Stachys officinallis, Isolation of biologically active substaces from the aerial parts of the plant. Journal Khim Prir Soedin. 2:1986;239-240.
14. Kotsos M., Aligiannis N., Mitaku S., Skaltsounis A.L., Charvala C. Chemistry of plants from Crete: stachys pinoside, a new flavonoid glycoside and iridoids from Stachys spinosa. Natural Product Letters. 15:2001;377-386.
15. Lister R.G. The effects of repeated doses of ethanol on exploration and its habituation. Psychopharmacology (Berl). 92:1987;78-83.
16. Mimura M., Namiki A., Kishi R., Ikeda T., Miyake H. Antagonistic effect of physostigmine on ketamine-induced anesthesia. Psychopharmacology (Berl). 102:1990;399-403.
17. Miyase T., Yamamoto R., Ueno A. Phenylethanoid glycosides from Stachys officinalis. Phytochemistry. 43:1996;475-479.
18. Mozaffarian, V., 1996. A dictionary of Iranian plant names, Farahang Moaser, Tehran, p. 522.
19. Paternostro M.P., Maggio A.M., Piozzi F., Servettaz O. Labdane diterpenes from Stachys plumosa. Journal of Natural Products. 63:2000;1166-1167.
20. Pellow S., File S.E. Anxiolytic and anxiogenic drug effects on exploratory activity in an elevated plus-maze: a novel test of anxiety in the rat. Pharmacology, Biochemistry and Behavior. 24:1986;525-529.
21. Rabbani M., Wright E.J., Little H.J. Tolerance to competitive NMDA antagonists, but no crosstolerance with barbiturates. Pharmacology, Biochemistyr and Behavior. 50:1995;9-15.
22. Rodgers R.J., Cao B.J., Dalvi A., Holmes A. Animal models of anxiety: an ethological perspective. Brazilian Journal of Medical and Biological Research. 30:1997;289-304.
23. Sezik E., Basaran A. Phytochemical investigations on the plants used as folk medicine and herbal tea in Turkey: II. Essential oil of Stachys lavandulifolia Vahl. Journal of Faculty of Pharmacy of Ankara University. 21:1985;98-107.
24. Soderpalm B., Hjorth S., Engel J.A. Effects of 5-HT1A receptor agonists and L-5-HTP in Montgomery's conflict test. Pharmacology Biochemistry and Behavior. 32:1989;259-265.
25. Treit D. Animal models for the study of anti-anxiety agents: a review. Neuroscience Biobehavior Review. 9:1985;203-222.
26. Vogel J.R., Beer B., Clody D.E. A simple and reliable conflict procedure for testing anti-anxiety agents. Psychopharmacologia. 21:1971;1-7.
27. Winslow J.T., Insel T.R. Infant rat separation is a sensitive test for novel anxiolytics. Progress in Neuro-psychopharmacology and Biological Psychiatry. 15:1991;745-757.
28. Yamamoto R., Miyase T., Ueno T. Stachyssaponins I-VIII new oleanane-type triterpene saponins from Stachys riederi Chamisso. Chemical and Pharmaceutical Bulletin. 42:1994;1291-1296.